HFE遺伝性血色素症の人の平均余命はどれくらいですか?

HFE遺伝性血色素症の人々の平均余命およびHFE遺伝性血色素症における最近の進歩および研究

元の


Studies indicate that persons with symptomatic haemochromatosis have somewhat reduced life expectancy compared to the general population. This is mainly due to excess mortality from cirrhosis and liver cancer. Patients who were treated with phlebotomy lived longer than those who weren't. Patients without liver disease or diabetes had similar survival rate to the general population. Stem cell research is showing promising signs

Translated